Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May-Jun;35(3):419-421.
doi: 10.25259/IJN_418_2024. Epub 2025 Feb 20.

Nasal Methicillin Resistant Staphylococcus Aureus Colonisation and the Incidence of Invasive Staphylococcal Infection in Patients Undergoing Hemodialysis

Affiliations

Nasal Methicillin Resistant Staphylococcus Aureus Colonisation and the Incidence of Invasive Staphylococcal Infection in Patients Undergoing Hemodialysis

Navya Mathew et al. Indian J Nephrol. 2025 May-Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1:
Figure 1:
Isolation of pathogens in invasive infections in the follow up period. MSSA: Methicillin-sensitive Staphylococcus aureus.

Similar articles

References

    1. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant staphylococcus aureus: An overview of basic and clinical research. Nat Rev Microbiol. 2019;17:203–18. doi: 10.1038/s41579-018-0147-4. - DOI - PMC - PubMed
    1. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173:1970–8. doi: 10.1001/jamainternmed.2013.10423. - DOI - PMC - PubMed
    1. CLSI . Performance standards for antimicrobial susceptibility testing. 30th ed. Clinical and Laboratory Standards Institute; 2023. CLSI document M100.
    1. U.S. Centers for Disease Control and Prevention . The National Healthcare Safety Network (NHSN) Manual: NHSN [2022] Toolkit and Guidance for External Validation. Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases; https://www.cdc.gov/nhsn/pdfs/validation/2022/2022-nhsn-ev-guidance-508.pdf .
    1. Bassetti M, Del Puente F, Magnasco L, Giacobbe DR. Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: Advances in phase I and II trials. Expert Opin Investig Drugs. 2020;29:495–506. doi: 10.1080/13543784.2020.1750595. - DOI - PubMed

LinkOut - more resources